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Abstract
Salmonella enterica subsp. enterica serovar 4,[5],12:i:- is a monophasic variant of Salmonella Typhimurium. In this
study, a total of 651 human and 107 food and environmental isolates of serovar 4,[5],12:i:- recovered from 2007
through 2011 in Switzerland were characterized by antibiotic resistance profiles and pulsed-field gel electro-
phoresis (PFGE). In addition, a selection of isolates belonging to the most frequent PFGE patterns was further
subjected to multilocus variable-number tandem-repeat analysis (MLVA) and phage typing. Over the years
2007–2011, the reports of salmonellosis caused by Salmonella enterica serovar 4,[5],12:i:- significantly increased. A
high prevalence of multidrug-resistant isolates, mainly showing an ampicillin–streptomycin–sulfonamide–
tetracycline resistance pattern (ASSuT), was observed. In addition, four extended spectrum beta lactamase
(ESBL) (CTX-M-55)–producing isolates were found. XbaI PFGE analysis of all isolates revealed over 150 different
pulsotypes, and generally showed a considerable diversity within the monophasic isolates. Nevertheless, among
these we identified seven dominant profiles, which encompassed 66% of all isolates tested. The PFGE type
STYMXB.0131 dominated among human as well as food isolates. Multilocus variable-number tandem-repeat
analysis profile 3-12-10-0-0211, which, in many cases, coincided with PFGE type STYMXB.0131 and phage type
DT193 were the most prevalent types found for the isolates further characterized by these typing methods. Our
data provide strong evidence for a spread of two specific Salmonella serovar 4,[5],12:i:- clones (PFGE pattern
STYMXB.0131, resistance type ASSuT) and (PFGE pattern STYMXB.0131, resistance type SSuT). In contrast to
the human isolates, the pork/poultry isolates expressed predominantly the SSuT resistance type.
Introduction
Nontyphoidal salmonellae are often acquired fromcontaminated food, and they are an important cause of
gastroenteritis and bacteremia, posing a worldwide threat to
public health (Rabsch et al., 2001). It is estimated that Salmo-
nella causes 93.8 million human infections and 155,000 deaths
annually worldwide (Majowicz et al., 2010).
Since the year 2009, S. enterica subsp. enterica serovar
4,[5],12:i:- ranks among the three most frequent serovars
found in Switzerland within the isolates submitted to the
National Centre for Enteropathogenic Bacteria and Listeria
for serotyping. It is known to be mainly a monophasic variant
of Salmonella Typhimurium with antigenic and genotypic
similarities (Echeita et al., 2001). As with other enteric sal-
monellae, infections due to serovar 4,[5],12:i:- commonly
manifest themselves as self-limiting gastroenteritis, but severe
invasive infections can also occur, which call for antimicrobial
treatment. In those cases, fluoroquinolones, trimethoprim-
sulfamethoxazole, ampicillin, or third-generation cephalo-
sporins come into consideration (Hohmann, 2001). The
emergence and spread of resistant bacteria and subsequent
treatment failure is a significant and increasing global public
health problem. A large proportion of the European serovar
4,[5],12:i:- strains is resistant to ampicillin, streptomycin, sul-
fonamides, and tetracycline, a resistance pattern (R-type) that
is abbreviated by ASSuT (Hopkins et al., 2010). The sources of
isolates causing human infections often turned out to be pigs
and pork products (Hauser et al., 2010; Rodrı´guez et al., 2012).
The objective of this study was to characterize human,
food, and environmental isolates of serovar 4,[5],12:i:- col-
lected from 2007 through 2011 in order to gain data about the
epidemiology, phenotypic and genetic diversity, and sus-
ceptibility to antimicrobials of this serovar circulating in
Switzerland. Such data provide a scientific basis for law-
enforcement actions by food safety authorities.
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Materials and Methods
Salmonella isolates
From 2007 through 2011, 8256 cases of Salmonella infection
were reported to the Swiss Federal Office of Public Health.
From this time span, 758 isolates of serovar 4,[5],12:i:- (651
from humans and 107 from food or environment [water]
samples) were selected for this study. Most of the 651 human
isolates were derived from stool samples. The remaining
isolates originated from urine (11), blood (5), or other sites
(44). More male (53.7%) than female cases (46.3%) were re-
corded. The average age for infection with Salmonella serovar
4,[5],12:i:- was 21 years (men: 19 years, women: 22 years).
Multiple isolates from the same patient or isolates from family
members were excluded. Nonhuman isolates (N = 107) origi-
nated from pork (N = 71), poultry (N = 22), the environment
(N = 8), and for 6 isolates the originwas unknown. All samples
had been collected and submitted to the National Centre for
Enteropathogenic Bacteria and Listeria by diagnostic labora-
tories, hospitals, or family doctors throughout Switzerland.
Antibiotic susceptibility testing
The isolates were tested for antimicrobial susceptibility by
the disk diffusion method according to the Performance
Standards for Antimicrobial Susceptibility Testing (CLSI,
2008). The panel of antibiotic disks (Becton, Dickinson and
Company, MD) consisted of ampicillin, amoxicillin/clavu-
lanic acid, cephalothin, cefotaxime (CTX), ciprofloxacin,
gentamicin, tetracycline, streptomycin, chloramphenicol,
kanamycin, nalidixic acid, sulfamethoxazole, and trimetho-
prim. The strains were classified as resistant, intermediate, or
susceptible to each antibiotic agent according to the CLSI
criteria. For calculations of percentages, intermediate sus-
ceptibility was considered as resistant. Isolates displaying
resistance to three or more antimicrobial compounds of dif-
ferent classes were defined as multidrug resistant.
Isolates whose resistance patterns demonstrated a synergy
effect between amoxicillin/clavulanic acid and CTX in the disk
diffusion test were further tested using E-Test extended spec-
trum beta lactamase (ESBL) strips (BioMe´rieux, Marcy l’Etoile,
France) containing CTX, cefepime, or ceftazidime alone and in
combination with clavulanic acid according to the manufac-
turer’s protocols (Brown et al., 2000). Confirmed ESBL pro-
ducers were analyzed for blaTEM, blaSHV, and blaCTX-M genes by
polymerase chain reaction (PCR) and by sequencing the whole
open reading frames of the responsible bla genes, using specific
primer sets (Pitout et al., 1998;Woodford et al., 2006; Geser et al.,
2012). Resulting amplicons were purified using the PCR Pur-
ification Kit (Qiagen, Courtaboeuf, France) according to the
manufacturer’s recommendations. Custom sequencing was
performed at Microsynth (Balgach, Switzerland) and the nu-
cleotide and protein sequences were analyzed with Codon
Code Aligner V. 3.7.1.1. For database searches, the BLASTN
program of National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov/blast/) was used.
PFGE typing
Pulsed-field gel electrophoresis (PFGE) was performed
using the restriction endonuclease XbaI (Roche, Mannheim,
Germany) by following the Centers for Disease Control and
Prevention (CDC) PulseNet protocol (http://www.cdc.gov/
pulsenet/protocols.htm). Salmonella serovar Braenderup
strain H9812 (ATCC BAA 664) was used as reference strain.
Gels were stained with ethidium bromide and visualized
under ultraviolet light transillumination with Gel Doc (Bio-
Rad, Munich, Germany). GelCompar II software (Applied
Maths NV, Sint-Martens-Latem, Belgium) was used for
analysis. Pairwise similarities between the XbaI PFGE pat-
terns were calculated by the DICE similarity coefficient.
Clustering was based on the unweighted pair-group method
with averages, setting tolerance at 1% and optimization at
1.5%. The most frequent PFGE profiles were compared with
profiles in the CDC PulseNet database and if possible as-
signed to reference strains of this database.
Multilocus variable-number tandem-repeat analysis
(MLVA) and phage typing
Moreover, from the seven most frequent PFGE patterns, 40
isolates representing the genetic and antimicrobial resistance
diversity were selected for MLVA and phage typing. MLVA
was based on the protocol by Lindstedt et al. (2004) using an
ABI 310 DNA Sequencer (Applied Biosystems, Darmstadt,
Germany) (Beutlich et al., 2011). For data evaluation, no-
menclature according to Larsson et al. (2009) was used. As-
signation of the phage type was done according to the
Anderson typing scheme (Anderson et al., 1977).
Results and Discussion
While the overall number of human salmonellosis cases in
Switzerland decreased from 2001 to 2011, the number of
FIG. 1. Percentage of human Salmonella enterica subsp.
enterica serovar 4,[5],12:i:- isolates with the ampicillin–
streptomycin–sulfonamide–tetracycline (ASSuT), streptomycin–
sulfamethoxazole–tetracycline (SSuT), ampicillin–streptomycin–
sulfonamide (ASSu) resistance patterns between 2007 and 2011.
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isolates with serovar 4,[5],12:i:- increased during the last 8
years. In 2007, serovar 4,[5],12:i:- accounted for 5.8% (95%
confidence interval [CI], 4.3; 7.6) of annual human Salmonella
isolates. For the following years, those figureswere as follows:
8.2% (95% CI, 6.7; 9.9) in 2008, 18.3% (95% CI, 15.9; 21.0) in
2009, 15.9% (95% CI, 13.6; 18.4) in 2010, and 18.2% (95% CI,
15.9; 20.7) in 2011, which was a significant change in the
prevalence ( p< 0.05).
A total of 327 isolates (43%) showed one to three resistances
and 424 isolates (56%) displayed more than three resistances,
whereas only seven isolates (1%) were fully susceptible
against the antibiotics tested. During the years 2007–2011, the
trend shifted toward theASSuT resistance pattern (Fig. 1). The
prevalence of ASSuT significantly increased from 35.4% (95%
CI, 22.2; 50.5) to 53.7% (95% CI, 46.3; 60.9) among the human
isolates ( p< 0.05). We found 64% of all serovar 4,[5],12:i:-
isolates resistant to ampicillin, 89% to streptomycin, 97% to
sulfamethoxazole, and 88% to tetracycline while at most 6%
of all isolates were resistant to any of the remaining nine
antibiotics.
The second most frequent pattern was resistance against
SSuT, with none recorded in 2007 and 24% detected in 2009
among human isolates. However, the SSuT patternwas found
most frequently among the nonhuman isolates (about 70%).
The third most common pattern included resistance against
ampicillin, sulfamethoxazole, and streptomycin (ASSu), and
was found in about 7% of all human isolates tested, but never
in nonhuman isolates.
Four human isolates expressed an ESBL phenotype
(Table 1). The patients were 1, 22, and 23 years (two persons)
of age. All four individuals lived in different cantons of
Switzerland. These isolates were collected between 2009 and
2011. A comparison of their corresponding PFGE results
showed different patterns for all four isolates (data not
shown). They also differed from other serovar 4,[5],12:i:- XbaI
PFGE patterns in Switzerland during this time period. PCR
results revealed that all four isolates were positive for genes
belonging to the TEM and the CTX-M families of b-lacta-
mases. Sequencing of the entire open reading frames includ-
ing flanking regions revealed the presence of blaTEM-1 and the
ESBL gene blaCTX-M-55. Three of the four affected patients had
a history of travel to Thailand shortly before disease onset. For
one patient, there was no recorded history of foreign travel.
Interestingly, CTX-M-55 was first reported from Thailand
(Kiratisin et al., 2007), and—according to subsequent
studies—remained endemic there. The fact that the four ESBL
producers yielded various PFGE patterns despite the patients’
similar anamnesis may well be explained by (1) the fact that
ESBL genes in Salmonella are plasmid mediated and plasmids
might spread independently to clonal spread of bacteria; (2)
the long time period (3 years) duringwhich they arose; and (3)
the dynamics of the occurrence of blaCTX-M-55 in Thailand, a
gene that was found there in Klebsiella pneumoniae, Escherichia
coli, and also in Salmonella (Kiratisin et al., 2007), implying
association with transferable plasmids.
XbaI PFGE analysis of the 758 isolates revealed over 150
different pulsotypes, and generally showed a considerable
diversity within the monophasic isolates. Nevertheless,
among these we identified seven dominant profiles (Fig. 2),
which encompassed 66% of all isolates tested. As many as
42% belonged to the PFGE-pattern STYMXB.0131 (Fig. 2,
identification code A), 13% to STYMXB.0079 (code B), and 4%
Table 1. Resistance Patterns of the Four blaCTX-M-55
Harboring Salmonella enterica Subsp. enterica
Serovar 4,[5],12:i:- Isolates
Strain Resistance pattern Travel history
N09-2591 A, S, Su, T, CF, CTX, G, C Thailand
N09-2709 A, S, Su, CF, CTX, K, G, C Thailand
N10-0857 A, S, Su, T, CF, CTX, C None recorded
N11-0562 A, S, Su, T, CF, CTX, K, G Thailand
FIG. 2. Dominant pulsed-field gel electrophoresis patterns (A–G) of Salmonella enterica subsp. enterica serovar 4,[5],12:i:-
during the years 2007–2011 in Switzerland. Profiles D, F, and G could not be assigned with reference strains of CDC PulseNet
database. This figure shows their next relatives (STYMXB.0080, STYMXB.0206, STYMXB.0330, STYMXB.0055, STYMXB.0301,
STYMXB.0199). Salmonella Braenderup H9812 was used as reference strain. Clustering was based on the unweighted pair-
group method with averages, setting tolerance at 1% and optimization at 1.5%.
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to STYMXB.0010 (code C) (Hopkins et al., 2010). Patterns
identified as codes D–G were found at rates below 3%. The
frequency of STYMXB.0131 among the annual human serovar
4,[5],12:i:- isolates tested was 8.3% (95% CI, 2.3; 20.0) (4/48) in
2007 and reached a peak of 47% (95% CI, 39.3; 54.9) (79/168)
in the year 2009. In contrast, the human STYMXB.0079 isolates
represented 20.8% (95% CI, 10.5; 35.0) (10/48) of all human
serovar 4,[5],12:i:- isolates in 2007 and decreased to 9.5% (95%
CI, 5.5; 15.0) (16/168) in 2009. The human STYMXB.0010
isolates were found at a rate of 25% (12/48) in 2007 and de-
creased to 0.6% (95% CI, 0.01; 3.3] (1/168) in 2009. Patterns
belonging to codes D–G showed no clear trend during this
time period. It is worth mentioning that a considerable pro-
portion, 118 of the 315 human ASSuT isolates (38%), was
identified as STYMXB.0131, rendering this pulsotype themost
frequent among the human isolates with the ASSuT resistance
pattern. STYMXB.0131 strains in combination with this
R-type were also frequently isolated in France, Germany,
England, and Wales (Bone et al., 2010; Hauser et al., 2010;
Hopkins et al., 2010). Interestingly, STYMXB.0131was also the
Table 2. Characterization Results of 40 Selected Salmonella enterica Subsp. enterica Serovar 4,[5],12:i:- Isolates
from the Most Common Pulsed-Field Gel Electrophoresis (PFGE) Profiles
PFGE profile Strain nr. MLVA profilea Phage type Resistance pattern
Profile A (STYMXB.0131) N08-1534b 3-11-9-0-0211 DT 193 ASSuT
N10-1394b 3-12-10-0-0211 DT 193 ASSuT
N08-1257b 3-12-10-0-0211 DT 193 SSuT
N08-2475c 3-12-10-0-0211 DT 193 SSuT
N10-0496c 3-12-10-0-0211 DT 193 SSuT
N10-2374b 3-12-10-0-0211 DT 193 SSuT
N11-0972b 3-12-10-0-0211 DT 193 SSuT
N11-1197c 3-12-10-0-0211 DT 193 SSuT
N09-2561c 3-12-10-0-0211 RDNCd SSuT
N08-1933e 3-13-10-0-0211 DT 193 ASSuT
N07-0563b 3-13-11-0-0211 DT 193 ASSuT
N07-0096b 3-13-9-0-0211 DT 193 ASSuT
N09-0165b 3-13-9-0-0211 DT 193 ASSuT
N11-2679b 3-13-9-0-0211 DT 193 ASSuT
N09-0942b 3-14-9-0-0211 DT 193 ASSu
Profile B (STYMXB.0079) N10-1200f 3-11-11-0-0211 DT 193 ASSuT
N11-0988b 3-12-10-0-0211 DT 104Blow SuT
N09-0920b 3-12-10-0-0211 DT 193 ASSuT
N08-0194b 3-12-10-0-0211 U311 ASSuT
N07-1933b 3-13-10-0-0211 DT 193 ASSuT
N10-2379b 3-13-10-0-0211 U311 ASSuT
N11-2063b 3-13-10-0-0211 U311 ASSuT
N08-1496c 3-13-9-0-0211 DT 193 ASSuT
N06-1830c 3-13-9-0-0211 DT 7 SSuT
N09-2019b 3-14-8-0-0211 DT 104Blow ASSuT-TMP
Profile C (STYMXB.0010) N09-0946b 3-12-10-0-0211 RDNC SuT
N08-0979b 3-13-8-0-0211 DT 104Blow ASSuT-TMP
N08-1358c 3-13-8-0-0211 DT 120 ASSuT-TMP
N10-1923b 3-13-9-0-0211 DT 104Blow SSuT-TMP
N11-0095b 3-14-9-0-0211 RDNC ASSuT
N07-2375b 3-8-9-0-0211 DT 120 SuT
N07-1209b 3-8-9-0-0211 U311 ASSuT
Profile D N11-2663b 3-14-9-0-0111 DT 193 ASSuT
N10-2046b 3-8-11-0-0211 DT 193 ASSuT
Profile E (STYMXB.0083) N11-2388b 3-11-9-0-0211 DT 104Blow ASSuT
N10-0984b 3-12-10-0-0211 DT 104Blow ASSuT
Profile F N10-1142b 3-13-8-0-0211 DT 193 ASSuT
N11-1000b 3-14-11-0-0211 DT 193 ASSuT
Profile G N11-2499b 3-12-10-0-0211 RDNC ASSuT-G-C
N11-1645b 3-13-11-0-0211 RDNC ASSuT
aSTTR 9-5-6-10-3.
bHuman origin.
cFood origin (pork).
dReaction pattern did not conform to the phage scheme.
eFood origin (poultry).
fEnvironmental origin.
MLVA, multilocus variable-number tandem-repeat analysis; ASSuT, ampicillin–streptomycin–sulfonamide–tetracycline resistance pattern;
SSuT, streptomycin–sulfamethoxazole–tetracycline resistance pattern; SuT, sulfamethoxazole–tetracycline resistance pattern; TMP, trimeth-
oprim; G, gentamicin; C, chloramphenicol.
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most prevalent pulsotype (60 of 71) among the monophasic
pork isolates (Fig. 2). Moreover, 11 of the 22 poultry isolates
belonged to this pulsotype (data not shown). In contrast to the
human isolates—but in accordance with the pork isolates—
the majority (7/11) of these poultry isolates expressed the
SSuT resistance type, compared to only 2/11 showing the
ASSuT. The Salmonella serovar 4,[5],12:i:- clone (PFGE pattern
STYMXB.0131, resistance type SSuT) was isolated from hu-
mans as well as from pork/poultry meat, which gave strong
evidence for an epidemiological link between pork/poultry
meat and human disease. Of the 96 isolates belonging to the
pulsotype STYMXB.0079, 52 corresponded to the ASSuT, and
two to the SSuT resistance pattern. This pulsotype in combi-
nation with the R-type ASSuT was predominantly isolated
from humans in Italy between 2003 and 2006 but not in other
European countries (Dionisi et al., 2009; Hopkins et al., 2010).
We speculate that this type was previously predominant in
Switzerland andwas replaced during the last several years by
pulsotype STYMXB.0131.
Based on the seven most common PFGE patterns found, 40
isolates were selected for further characterization withMLVA
and phage typing. The main focus was made on type
STYMXB.0131, of which 15 isolates of different origins, dates
of isolation, and resistance patterns were selected. From
the second most frequently encountered PFGE pattern—
STYMXB.0079—we chose 10 different isolates: from
STYMXB.0010 seven isolates and from the remaining four
patterns two isolates each.
Phage typing showed 10 different types with the following
distribution: 55% (22/40) belonged to DT193, 15% (6/40) to
DT104blow, 12.5% (5/40) were RDNC (reaction pattern did not
conform to the phage scheme), 10% (4/40) to U311, 5% (2/40) to
DT120, and 2.5% (1/40) to DT7. Among the RDNC patterns, no
commonality was found; therefore, they were counted as five
different types. Again, these findings supported those reported
earlierwith theEuropean 4,[5],12:i:- byHopkins et al. (2010, 2012).
MLVA typing showed 13 different allele combinations
(MLVAprofiles), all of themwith the same number of tandem
repeats at locus STTR9 and with absence of the virulence
plasmid locus STTR10 (Table 2). Differences were found at loci
STTR5, STTR6, and STTR3. Irrespective of the PFGE profile,
resistance pattern, or phage type, theMLVA profile 3-12-10-0-
0211 predominated with a percentage of 35% (14/40). As
illustrated in Table 2, profile 3-13-9-0-0211 appeared in 15%
(6/40) of the isolates, and no more than 10% of the isolates
could be assigned to any otherMLVAprofile. Only one isolate
with profile 3-14-9-0-0111 differed from the others at locus
STTR3. Locus STTR3with allele no. 0211 and locus STTR9with
allele no. 3 were also typically found in other European ser-
ovar 4,[5],12:i:- isolates and, similarly, locus STTR10 was
consistently absent, indicating the lack of the typical Salmo-
nella Typhimurium virulence plasmid in those isolates (Hau-
ser et al., 2010; Hopkins et al., 2010). Loci STTR5, STTR6, and
STTR9 appear to be highly variable among the European and
Swiss isolates.
Conclusions
In conclusion, XbaI PFGE analysis of all isolates revealed a
large variety of profiles within the monophasic isolates.
Nevertheless, among these we identified seven dominant
profiles, which encompassed 66% of all isolates tested.
Moreover, our data provide strong evidence for a spread of
two specific Salmonella serovar 4,[5],12:i:- clones (PFGE pat-
tern STYMXB.0131, resistance type ASSuT) and (PFGE pat-
tern STYMXB.0131, resistance type SSuT) during these years
in Switzerland. In contrast to the human isolates, the pork/
poultry isolates expressed predominantly the SSuT resistance
type. The Salmonella serovar 4,[5],12:i:- clone (PFGE pattern
STYMXB.0131, resistance type SSuT) was isolated from hu-
mans as well as from pork/poultry meat, which gives strong
evidence for an epidemiological link between pork/poultry
meat and human disease. Studies such as the one presented
here are able to provide sufficient scientific data to act as
grounds on which to base law-enforcement activities by food
safety authorities. For example, the fact that an important
percentage of the human morbidity is caused by one partic-
ular clone found in a particular and traceable product justifies
such action. Nevertheless, the limitations are also clearly
shown, in that other clones also contribute to morbidity.
Hence, precise studies help in fine-tuning legal actions.
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